期刊论文详细信息
Frontiers in Immunology
Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment
Immunology
Fu Peng1  Chunxi Li1  Qiaoling Wan1  Jianbo Zhou1  Zifan Ma1  Xue Wang1  Xin Li1 
[1] Department of Pharmacology, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, China;
关键词: pancreatic cancer;    cancer-associated fibroblasts;    fibrosis;    metabolic reprogramming;    crosstalk;    heterogeneity;   
DOI  :  10.3389/fimmu.2023.1152312
 received in 2023-01-27, accepted in 2023-03-09,  发布年份 2023
来源: Frontiers
PDF
【 摘 要 】

Pancreatic cancer is one of the most dangerous types of cancer today, notable for its low survival rate and fibrosis. Deciphering the cellular composition and intercellular interactions in the tumor microenvironment (TME) is a necessary prerequisite to combat pancreatic cancer with precision. Cancer-associated fibroblasts (CAFs), as major producers of extracellular matrix (ECM), play a key role in tumor progression. CAFs display significant heterogeneity and perform different roles in tumor progression. Tumor cells turn CAFs into their slaves by inducing their metabolic dysregulation, exacerbating fibrosis to acquire drug resistance and immune evasion. This article reviews the impact of metabolic reprogramming, effect of obesity and cellular crosstalk of CAFs and tumor cells on fibrosis and describes relevant therapies targeting the metabolic reprogramming.

【 授权许可】

Unknown   
Copyright © 2023 Li, Zhou, Wang, Li, Ma, Wan and Peng

【 预 览 】
附件列表
Files Size Format View
RO202310109897962ZK.pdf 1877KB PDF download
  文献评价指标  
  下载次数:1次 浏览次数:0次